![]() |
Volumn 100, Issue 12, 2006, Pages 1183-1186
|
Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA
|
Author keywords
Miltefosine; Pharmacokinetics; QT NASBA; Visceral leishmaniasis
|
Indexed keywords
METHOTREXATE;
MILTEFOSINE;
ADULT;
ANOREXIA;
ARTICLE;
BODY WEIGHT DISORDER;
CASE REPORT;
DIARRHEA;
DISEASE EXACERBATION;
DRUG BLOOD LEVEL;
DRUG FEVER;
DRUG HALF LIFE;
FATIGUE;
FOLLOW UP;
HEPATOSPLENOMEGALY;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LEISHMANIA INFANTUM;
LEUKOPENIA;
LIQUID CHROMATOGRAPHY;
MALAISE;
MALE;
MASS SPECTROMETRY;
NETHERLANDS;
NIGHT SWEAT;
NUCLEIC ACID AMPLIFICATION;
NUCLEOTIDE SEQUENCE;
PANCYTOPENIA;
PSORIATIC ARTHRITIS;
QUANTITATIVE ANALYSIS;
SYMPTOM;
THROMBOCYTOPENIA;
VISCERAL LEISHMANIASIS;
WEIGHT REDUCTION;
ADMINISTRATION, ORAL;
ANTIPROTOZOAL AGENTS;
HUMANS;
LEISHMANIASIS, CUTANEOUS;
LEISHMANIASIS, VISCERAL;
MALE;
MIDDLE AGED;
PHOSPHORYLCHOLINE;
PSORIASIS;
SELF-SUSTAINED SEQUENCE REPLICATION;
TREATMENT OUTCOME;
LEISHMANIA INFANTUM;
|
EID: 33749052069
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trstmh.2006.01.002 Document Type: Article |
Times cited : (21)
|
References (5)
|